This NDC is on FDA's drug shortage list (posted Jun 6, 2018)
Reported reason: Demand increase for the drug
Product Information
KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Fosun Pharma USA Inc., priced at $0.4980 per ML under NDC 72266011925. Its NADAC has been published 342 times since Feb 5, 2020.
FDA first approved this application on Nov 1, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/mL
Manufacturer
Fosun Pharma USA Inc.NDC
72266011925
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA204216FDA Approved
11/1/2016
TE Code
AP
On Market Since
6/23/2023
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 342 times since Feb 5, 2020, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4980 per ML |
|---|---|
| All-time high | $1.1575 (Mar 11, 2020) |
| All-time low | $0.4543 (Feb 18, 2026) |
| 52-week high | $0.5738 |
| 52-week low | $0.4543 |
| Median price | $0.7640 |
| Average price | $0.7714 |
| Largest weekly change | +26.3% (May 18, 2022) |
| Weeks tracked | 342 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Fosun Pharma USA Inc., is $0.4980 per ML (NDC 72266011925), effective Aug 19, 2026.
How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 56.8%. It has been tracked across 342 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?
Since Feb 5, 2020, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $1.1575 (Mar 11, 2020), with a median of $0.7640 per ML.
Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 60 MG/2 ML VIAL?
KETOROLAC 60 MG/2 ML VIAL (NDC 72266011925) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.
Is KETOROLAC 60 MG/2 ML VIAL in shortage?
Yes — NDC 72266011925 is currently listed in FDA's drug shortage database (posted Jun 6, 2018). Reported reason: Demand increase for the drug.